| Literature DB >> 26525535 |
Vishal Singh1, Benoit Chassaing2, Limin Zhang3, Beng San Yeoh1, Xia Xiao1, Manish Kumar1, Mark T Baker2, Jingwei Cai4, Rachel Walker1, Kamil Borkowski1, Kevin J Harvatine5, Nagendra Singh6, Gregory C Shearer1, James M Ntambi7, Bina Joe8, Andrew D Patterson4, Andrew T Gewirtz2, Matam Vijay-Kumar9.
Abstract
The gut microbiota plays a key role in host metabolism. Toll-like receptor 5 (TLR5), a flagellin receptor, is required for gut microbiota homeostasis. Accordingly, TLR5-deficient (T5KO) mice are prone to develop microbiota-dependent metabolic syndrome. Here we observed that T5KO mice display elevated neutral lipids with a compositional increase of oleate [C18:1 (n9)] relative to wild-type littermates. Increased oleate contribution to hepatic lipids and liver SCD1 expression were both microbiota dependent. Analysis of short-chain fatty acids (SCFAs) and (13)C-acetate label incorporation revealed elevated SCFA in ceca and hepatic portal blood and increased liver de novo lipogenesis in T5KO mice. Dietary SCFAs further aggravated metabolic syndrome in T5KO mice. Deletion of hepatic SCD1 not only prevented hepatic neutral lipid oleate enrichment but also ameliorated metabolic syndrome in T5KO mice. Collectively, these results underscore the key role of the gut microbiota-liver axis in the pathogenesis of metabolic diseases.Entities:
Keywords: Toll-like receptor 5; gut bacteria; hepatic neutral lipids; low-grade inflammation; metabolic diseases; monounsaturated fatty acids; short-chain fatty acids
Mesh:
Substances:
Year: 2015 PMID: 26525535 PMCID: PMC4670569 DOI: 10.1016/j.cmet.2015.09.028
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287